527 results on '"Tepe, Gunnar"'
Search Results
52. Stents With Torsional Strength for Superficial Femoral Artery Disease: The Prospective Q3-Registry
53. Correction to:Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry (CardioVascular and Interventional Radiology, (2021), 44, 2, (207-217), 10.1007/s00270-020-02663-7)
54. CORRIGENDUM to Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease:12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry (J Endovasc Ther., (2020), 27, 2, (304-315), 10.1177/1526602819898804)
55. Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial
56. Silicon carbide coating of nitinol stents to increase antithrombogenic properties and reduce nickel release
57. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
58. Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions
59. CORRIGENDUM to Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
60. GP IIb/IIIa Blockade During Peripheral Artery Interventions
61. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg
62. Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty
63. Evaluation of various image reconstruction parameters in lower extremity stents using multidetector-row CT angiography: initial findings
64. Superficial femoral artery: current treatment options
65. Reduction of Intimal Hyperplasia withRe-188-labeled Stents in a Rabbit Model at 7and 26 Weeks: An Experimental Study
66. Reply: Drug-Coated Balloons for Complex PAD: More Study Is Needed
67. Frequent Embolization in Peripheral Angioplasty: Detection with an Embolism Protection Device (AngioGuard) and Electron Microscopy
68. High-Grade, Non-Flow-Limiting Dissections Do Not Negatively Impact Long-term Outcome After Paclitaxel-Coated Balloon Angioplasty: An Additional Analysis From the THUNDER Study
69. Twelve-Month Results of a Randomized Trial Comparing Mono With Dual Antiplatelet Therapy in Endovascularly Treated Patients With Peripheral Artery Disease
70. Economic Value of Thrombolysis with Adjunctive Abciximab in Patients with Subacute Peripheral Arterial Occlusion
71. Drug-Eluting Stents for Infrainguinal Occlusive Disease: Progress and Challenges
72. Reduced thrombogenicity of nitinol stents—In vitro evaluation of different surface modifications and coatings
73. New Approach to Protected Percutaneous Transluminal Angioplasty in the Lower Limbs
74. Recanalization of Femoropopliteal Chronic Total Occlusions Using the ENABLER-P Balloon Catheter System
75. Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee: Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical Study
76. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial
77. Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
78. BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries
79. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
80. Intravascular Lithotripsy for Treatment of Calcified Lower Extremity Arterial Stenosis: Initial Analysis of the Disrupt PAD III Study
81. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial
82. Sirolimus-Eluting versus Bare Nitinol Stent for Obstructive Superficial Femoral Artery Disease: The SIROCCO II Trial
83. 19-0467_suppl_tables – Supplemental material for Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
84. Local Paclitaxel Delivery in Peripheral Vascular Disease
85. Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease
86. Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery: Long-term Results From the SIROCCO Trial
87. Prevention of Carotid Artery Restenosis After Sirolimus-Coated Stent Implantation in Pigs
88. Complication after embolization of a complex renal vascular malformation
89. PTFE-Covered Self-Expanding Nitinol Stents for the Treatment of Severe Iliac and Femoral Artery Stenoses and Occlusions: Final Results From a Prospective Study
90. Radiopacity of Current Endovascular Stents: Evaluation in a Multiple Reader Phantom Study
91. Evaluation of Magnetic Navigation in an In Vitro Model of Uterine Artery Embolization
92. Reteplase Monotherapy and Reteplase/Abciximab Combination Therapy in Peripheral Arterial Occlusive Disease: Results from the RELAX Trial
93. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients
94. Drug-eluting Stents: Potential Applications for Peripheral Arterial Occlusive Disease
95. Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
96. COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
97. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study
98. Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
99. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
100. Real-world outcomes of endovascular treatment in a non-selected population with peripheral artery disease – prospective study with 2-year follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.